Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test in Patients At Extremely High Risk of Postoperative Venous Thromboembolism.

NCT04710732 is registered in ClinicalTrials.gov with Pirogov Russian National Research Medical University as lead sponsor.

NCT NCT04710732
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04710732 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Individual Dose Adjustment of Low-molecular-weight-heparin by Thromodynamics Test in Patients At Extremely High Risk of Postoperative Venous Thromboembolism.
Lead sponsor
Pirogov Russian National Research Medical University
Phase
Phase 4
Overall status
Terminated
Start date
March 1, 2021
Completion date
January 31, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

venous thromboembolism